Skip to main content
Loading page, please wait…
HomeCurrent AffairsEditorialsGovt SchemesLearning ResourcesUPSC SyllabusPricingAboutBest UPSC AIUPSC AI ToolAI for UPSCUPSC ChatGPT

© 2026 Vaidra. All rights reserved.

PrivacyTerms
Vaidra Logo
Vaidra

Top 4 items + smart groups

UPSC GPT
New
Current Affairs
Daily Solutions
Daily Puzzle
Mains Evaluator

Version 2.0.0 • Built with ❤️ for UPSC aspirants

AI‑Driven Drug Discovery Workshop at CSIR‑HRDC, Ghaziabad – Training for Scientists (Apr 7‑9 2026) | GS3 UPSC Current Affairs April 2026
AI‑Driven Drug Discovery Workshop at CSIR‑HRDC, Ghaziabad – Training for Scientists (Apr 7‑9 2026)
From 7‑9 April 2026, CSIR‑HRDC, Ghaziabad hosted a three‑day workshop on AI‑driven drug discovery for CSIR scientists. The programme featured lectures on AI‑based target identification, biomarker discovery, molecular docking and bimolecular simulation, highlighting India’s push to integrate advanced technology into pharmaceutical research.
Overview A three‑day intensive workshop titled “AI‑Driven Drug Discovery: Advanced Tools, Techniques & Applications” was held at the CSIR -Human Resource Development Centre (CSIR‑HRDC), Ghaziabad from 7 to 9 April 2026 . The programme targeted CSIR scientists and technical officers, aiming to impart practical knowledge of cutting‑edge AI tools that are reshaping Drug Discovery . Key Developments Inauguration by Prof. G. N. Sastry (Dept. of Biotechnology, IIT Hyderabad), Dr. T. S. Rana (Head, CSIR‑HRDC) and other dignitaries, highlighting AI’s transformative impact. Lectures by experts from NIPER, IBAB, TCS, CSIR‑NEIST and IITs covering AI‑enabled Target Identification , Biomarker discovery, Molecular Docking & scoring, and Bimolecular Simulation . Hands‑on sessions by Dr. Rajnish Kumar (IIT BHU), Dr. Firoz Khan (CSIR‑CIMAP) and Dr. Tarak Karmakar (IIT Delhi) providing practical exposure to AI‑driven computational pipelines. Certificate distribution and valedictory address by Mrs. Preeti Chaudhary , acknowledging active participation. Important Facts Venue: CSIR‑HRDC, Ghaziabad. Participants: CSIR scientists and technical officers (exact number not disclosed). Organisers: Ministry of Science & Technology, CSIR‑HRDC. Feedback: Highly positive, forming a template for future capacity‑building programmes. UPSC Relevance The workshop underscores the growing convergence of AI with biotechnology, a theme increasingly featured in GS‑3 (Science & Technology) and GS‑4 (Ethics of emerging tech). Understanding AI‑driven drug discovery helps aspirants grasp India’s strategic push for high‑end R&D, public‑private partnerships, and the role of institutions like CSIR in translating research to health outcomes. Way Forward Building on the positive response, the Ministry plans to organize similar workshops across other CSIR labs, incorporate AI modules into regular training curricula, and foster collaborations with industry and academia to accelerate drug pipelines. Aspirants should monitor such initiatives as indicators of India’s innovation ecosystem and potential policy directions in health‑tech and biotech sectors.
  1. Home
  2. Prepare
  3. Current Affairs
  4. AI‑Driven Drug Discovery Workshop at CSIR‑HRDC, Ghaziabad – Training for Scientists (Apr 7‑9 2026)
Login to bookmark articles
Login to mark articles as complete

Overview

gs.gs373% UPSC Relevance

AI‑driven drug discovery workshops signal India's push for high‑end biotech R&D

Key Facts

  1. The three‑day workshop on AI‑Driven Drug Discovery was held at CSIR‑HRDC, Ghaziabad from 7‑9 April 2026.
  2. Organised by the Ministry of Science & Technology in collaboration with CSIR‑HRDC and leading academic‑industry partners (IITs, NIPER, TCS, CSIR‑NEIST).
  3. Target audience: CSIR scientists and technical officers, providing hands‑on training in AI‑enabled target identification, biomarker discovery, molecular docking and bimolecular simulation.
  4. Key speakers included Prof. G.N. Sastry (IIT Hyderabad), Dr. T.S. Rana (CSIR‑HRDC) and experts from NIPER, IBAB, TCS, CSIR‑NEIST, IIT BHU, IIT Delhi.
  5. The workshop introduced AI tools such as deep‑learning based virtual screening, generative models for molecule design, and reinforcement‑learning driven docking pipelines.
  6. Feedback was highly positive and the Ministry plans to replicate the programme across other CSIR labs, integrating AI modules into regular training curricula.

Background & Context

AI is transforming drug discovery by reducing time and cost through in‑silico screening, a priority under India’s ‘Atmanirbhar Bharat’ biotech agenda. CSIR, as the apex R&D body, is spearheading capacity‑building to align public research with industry and global standards, linking GS‑3 themes of emerging technologies and health innovation.

UPSC Syllabus Connections

Essay•Science, Technology and SocietyGS3•Developments in science and technology and their applicationsEssay•Education, Knowledge and CulturePrelims_GS•Science and Technology ApplicationsEssay•Economy, Development and InequalityGS3•IT, Space, Computers, Robotics, Nano-technology, Bio-technology and IPR

Mains Answer Angle

GS‑3: Discuss the strategic importance of AI‑driven drug discovery for India’s health security and biotech ecosystem, and suggest policy measures to foster AI‑biotech integration.

Full Article

<h2>Overview</h2> <p>A three‑day intensive workshop titled “AI‑Driven Drug Discovery: Advanced Tools, Techniques & Applications” was held at the <span class="key-term" data-definition="Council of Scientific & Industrial Research — India’s premier R&D organization under the Ministry of Science & Technology (GS1: Institutions)">CSIR</span>-Human Resource Development Centre (CSIR‑HRDC), Ghaziabad from <strong>7 to 9 April 2026</strong>. The programme targeted CSIR scientists and technical officers, aiming to impart practical knowledge of cutting‑edge <span class="key-term" data-definition="Artificial Intelligence — technology enabling machines to mimic human cognition; increasingly used in scientific research and drug design (GS3: Technology & Innovation)">AI</span> tools that are reshaping <span class="key-term" data-definition="Drug Discovery — systematic process of identifying new therapeutic candidates, from target selection to clinical testing (GS3: Biotechnology)">Drug Discovery</span>.</p> <h3>Key Developments</h3> <ul> <li>Inauguration by <strong>Prof. G. N. Sastry</strong> (Dept. of Biotechnology, IIT Hyderabad), <strong>Dr. T. S. Rana</strong> (Head, CSIR‑HRDC) and other dignitaries, highlighting AI’s transformative impact.</li> <li>Lectures by experts from NIPER, IBAB, TCS, CSIR‑NEIST and IITs covering AI‑enabled <span class="key-term" data-definition="Target Identification — early stage of drug discovery where specific disease‑related molecules are pinpointed (GS3: Biotechnology)">Target Identification</span>, <span class="key-term" data-definition="Biomarker — measurable biological indicator used for disease diagnosis and drug response monitoring (GS3: Health & Medicine)">Biomarker</span> discovery, <span class="key-term" data-definition="Molecular Docking — computational method to predict binding orientation of a drug candidate with its target protein (GS3: Computational Chemistry)">Molecular Docking</span> & scoring, and <span class="key-term" data-definition="Bimolecular Simulation — computer‑based modeling of interactions between two molecules to study stability and dynamics (GS3: Computational Chemistry)">Bimolecular Simulation</span>.</li> <li>Hands‑on sessions by <strong>Dr. Rajnish Kumar</strong> (IIT BHU), <strong>Dr. Firoz Khan</strong> (CSIR‑CIMAP) and <strong>Dr. Tarak Karmakar</strong> (IIT Delhi) providing practical exposure to AI‑driven computational pipelines.</li> <li>Certificate distribution and valedictory address by <strong>Mrs. Preeti Chaudhary</strong>, acknowledging active participation.</li> </ul> <h3>Important Facts</h3> <ul> <li>Venue: CSIR‑HRDC, Ghaziabad.</li> <li>Participants: CSIR scientists and technical officers (exact number not disclosed).</li> <li>Organisers: Ministry of Science & Technology, CSIR‑HRDC.</li> <li>Feedback: Highly positive, forming a template for future capacity‑building programmes.</li> </ul> <h3>UPSC Relevance</h3> <p>The workshop underscores the growing convergence of <span class="key-term" data-definition="Artificial Intelligence — technology enabling machines to mimic human cognition; increasingly used in scientific research and drug design (GS3: Technology & Innovation)">AI</span> with biotechnology, a theme increasingly featured in GS‑3 (Science & Technology) and GS‑4 (Ethics of emerging tech). Understanding AI‑driven drug discovery helps aspirants grasp India’s strategic push for high‑end R&D, public‑private partnerships, and the role of institutions like <span class="key-term" data-definition="Council of Scientific & Industrial Research — India’s premier R&D organization under the Ministry of Science & Technology (GS1: Institutions)">CSIR</span> in translating research to health outcomes.</p> <h3>Way Forward</h3> <p>Building on the positive response, the Ministry plans to organize similar workshops across other CSIR labs, incorporate AI modules into regular training curricula, and foster collaborations with industry and academia to accelerate drug pipelines. Aspirants should monitor such initiatives as indicators of India’s innovation ecosystem and potential policy directions in health‑tech and biotech sectors.</p>
Read Original on pib

Analysis

Practice Questions

GS3
Easy
Prelims MCQ

AI applications in drug discovery

1 marks
4 keywords
GS3
Medium
Mains Short Answer

Strategic importance of AI in biotech

5 marks
5 keywords
GS3
Hard
Mains Essay

AI in pharmaceutical research and governance

20 marks
6 keywords
Related:Daily•Weekly

Loading related articles...

Loading related articles...

Tip: Click articles above to read more from the same date, or use the back button to see all articles.

Quick Reference

Key Insight

AI‑driven drug discovery workshops signal India's push for high‑end biotech R&D

Key Facts

  1. The three‑day workshop on AI‑Driven Drug Discovery was held at CSIR‑HRDC, Ghaziabad from 7‑9 April 2026.
  2. Organised by the Ministry of Science & Technology in collaboration with CSIR‑HRDC and leading academic‑industry partners (IITs, NIPER, TCS, CSIR‑NEIST).
  3. Target audience: CSIR scientists and technical officers, providing hands‑on training in AI‑enabled target identification, biomarker discovery, molecular docking and bimolecular simulation.
  4. Key speakers included Prof. G.N. Sastry (IIT Hyderabad), Dr. T.S. Rana (CSIR‑HRDC) and experts from NIPER, IBAB, TCS, CSIR‑NEIST, IIT BHU, IIT Delhi.
  5. The workshop introduced AI tools such as deep‑learning based virtual screening, generative models for molecule design, and reinforcement‑learning driven docking pipelines.
  6. Feedback was highly positive and the Ministry plans to replicate the programme across other CSIR labs, integrating AI modules into regular training curricula.

Background

AI is transforming drug discovery by reducing time and cost through in‑silico screening, a priority under India’s ‘Atmanirbhar Bharat’ biotech agenda. CSIR, as the apex R&D body, is spearheading capacity‑building to align public research with industry and global standards, linking GS‑3 themes of emerging technologies and health innovation.

UPSC Syllabus

  • Essay — Science, Technology and Society
  • GS3 — Developments in science and technology and their applications
  • Essay — Education, Knowledge and Culture
  • Prelims_GS — Science and Technology Applications
  • Essay — Economy, Development and Inequality
  • GS3 — IT, Space, Computers, Robotics, Nano-technology, Bio-technology and IPR

Mains Angle

GS‑3: Discuss the strategic importance of AI‑driven drug discovery for India’s health security and biotech ecosystem, and suggest policy measures to foster AI‑biotech integration.

Explore:Current Affairs·Editorial Analysis·Govt Schemes·Study Materials·Previous Year Questions·UPSC GPT